Clinical trial
F573 for Injection Phase Ia Clinical Trial.
NCT04820049 is registered in ClinicalTrials.gov with Beijing Continent Pharmaceutical Co, Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- F573 for Injection Phase Ia Clinical Trial.
- Lead sponsor
- Beijing Continent Pharmaceutical Co, Ltd.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- February 8, 2021
- Completion date
- November 6, 2022
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pharmacokinetic, tolerance